Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-management of exudative AMD with Avastin and doxycycline
IRCT2015020921017N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2017
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bevacizumab and doxycycline in exudative macular degeneration, sponsored by Tehran University of Medical Sciences. Started Aug 2017; status: completed.
02
Drugs
bevacizumabdoxycycline
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on IRCT2015020921017N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015020921017N1.